Pathway to Cures (P2C) is a venture philanthropy fund created specifically to accelerate the development of cures across all inheritable blood and bleeding disorders. As a flexible partner working collaboratively with other organizations, P2C makes investments in innovative therapies and technologies, leveraging the deep resources and scientific community relationships of the National Bleeding Disorders Foundation (NBDF). By reinvesting proceeds from investments back into the Fund, P2C will amplify our impact by supporting the progress of promising companies and building a deep and diverse portfolio of investments that further our mission.